Cite
Juarez JE, Romero T, Mantz CA, et al. Toxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control Series. Adv Radiat Oncol. 2021;6(6):100759doi: 10.1016/j.adro.2021.100759.
Juarez, J. E., Romero, T., Mantz, C. A., Pepin, A., Aghdam, N., Suy, S., Steinberg, M. L., Levin-Epstein, R. G., Nickols, N. G., Kaplan, I. D., Meier, R. M., Pham, H. T., Linson, P. W., Hong, R. L., Buyyounouski, M. K., Bagshaw, H. P., Fuller, D. B., Katz, A. J., Loblaw, A., Collins, S. P., & Kishan, A. U. (2021). Toxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control Series. Advances in radiation oncology, 6(6), 100759. https://doi.org/10.1016/j.adro.2021.100759
Juarez, Jesus E, et al. "Toxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control Series." Advances in radiation oncology vol. 6,6 (2021): 100759. doi: https://doi.org/10.1016/j.adro.2021.100759
Juarez JE, Romero T, Mantz CA, Pepin A, Aghdam N, Suy S, Steinberg ML, Levin-Epstein RG, Nickols NG, Kaplan ID, Meier RM, Pham HT, Linson PW, Hong RL, Buyyounouski MK, Bagshaw HP, Fuller DB, Katz AJ, Loblaw A, Collins SP, Kishan AU. Toxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control Series. Adv Radiat Oncol. 2021 Aug 28;6(6):100759. doi: 10.1016/j.adro.2021.100759. eCollection 2021. PMID: 34585025; PMCID: PMC8453194.
Copy
Download .nbib